Below is an educational, technical answer to a question many patients and clinicians ask. The specific combination of wires, balloons, atherectomy, and stents is determined by the interventional cardiologist based on lesion complexity, calcification, and overall clinical picture. As a medical device manufacturer, INVAMED develops technologies in this area; the information here is educational and not medical advice.
Background: Coronary Artery Disease and Percutaneous Coronary Intervention
During PCI a lesion is usually crossed with a guidewire, prepared with a balloon, and in most cases scaffolded with a stent that holds the vessel open. When a narrowing becomes flow-limiting, patients may experience angina on exertion, and an abrupt plaque rupture with thrombosis can precipitate a myocardial infarction. Percutaneous coronary intervention (PCI) is a catheter-based approach that reaches the coronary arteries through a small arterial access point, typically the radial or femoral artery.
What should be avoided after stent placement?
General guidance often emphasizes not stopping prescribed antiplatelet medication and following activity and wound-care instructions after the procedure. Managing cardiovascular risk factors such as blood pressure, cholesterol, and smoking is commonly advised to support the treated artery. Any specific restrictions depend on the individual and the access site used. Patients should follow the personalized instructions provided by their own clinical team.
What This Means in Practice
Thin-strut cobalt-chromium platforms are intended to balance deliverability with radial support in a range of vessel sizes. Guide extension catheters can provide the backup support needed to deliver devices in tortuous or distal anatomy. Lesion calcification is a central factor in planning, and heavily calcified plaque may call for rotational atherectomy before ballooning or stenting.
Key Considerations
- Lesion calcification is a central factor in planning, and heavily calcified plaque may call for rotational atherectomy before ballooning or stenting.
- Thin-strut cobalt-chromium platforms are intended to balance deliverability with radial support in a range of vessel sizes.
- Guide extension catheters can provide the backup support needed to deliver devices in tortuous or distal anatomy.
Frequently Asked Questions
What drug does the ATLAS stent release?
According to INVAMED, the ATLAS DES elutes sirolimus at 1 microgram per square millimeter with a sustained controlled-release profile.
What is the regulatory status of these coronary devices?
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.
Who decides between PCI and bypass surgery?
That decision is made by a clinical heart team based on coronary anatomy and individual factors; this article is educational and not medical advice.
Clinical and Technical Context
Plaque modification is typically a preparatory step, and its use is decided by the operator based on the calcium burden seen on imaging. Because a drug-coated balloon leaves nothing behind, it is one option a clinician may weigh when a metallic implant is less desirable. Whether a closure device is used, and which type, is determined by access site, sheath size, and clinician preference. INVAMED's ATLAS system elutes sirolimus at 1 microgram per square millimeter with a sustained controlled-release profile designed to cover the early healing window. INVAMED's coronary portfolio includes guiding catheters, extension catheters, and microcatheters intended to support crossing and delivery in demanding anatomy. Thin-strut cobalt-chromium platforms are intended to balance deliverability with radial support in a range of vessel sizes. INVAMED's Extender Drug Eluting PTCA Balloon Catheter carries a paclitaxel coating for this local drug-delivery role. INVAMED's TemREN Rotablator uses diamond-coated burrs that ablate calcified plaque while preserving elastic tissue, according to the manufacturer.
Related on INVAMED
- Coronary Artery Disease & Cardiac Interventions — product category
- Atlas Coronary Stent System Cobalt Chromium — Technical Overview
- Sirolimus-Eluting Stent Platform: Technology, Uses and Considerations
- Inside the ATLAS Drug Eluting Coronary Stent System Cobalt Chromium: Design and Applications
Important Disclaimer
This article is intended for general educational and technical information about medical device technologies. It is not medical advice, a diagnosis, or a treatment recommendation, and it does not replace consultation with a qualified healthcare professional. Any decision about diagnosis or treatment should be made by a licensed clinician based on an individual assessment. INVAMED devices are intended for use by trained healthcare professionals in accordance with the applicable Instructions for Use (IFU) and local regulatory approvals. Product availability and indications vary by country.
Reviewed by the INVAMED Medical Affairs team. Content is educational and technical in nature.